Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 13Head & Neck 3Dermatologic 3Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 2Gastrointestinal 2Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Uveal Melanoma 1Melanoma 1Keratosis, Actinic 1

Interventions

pembrolizumab 339Nivolumab 305Ipilimumab 274Cyclophosphamide 194aldesleukin 148Interleukin-2 110fludarabine phosphate 106trametinib 85Temozolomide 83Dacarbazine 81fludarabine 80dabrafenib 77Radiotherapy 75Biopsy 75Vemurafenib 71Imiquimod 53Bevacizumab 51sargramostim 50Radiosurgery 49Peripheral Blood Stem Cell Transplantation 49Paclitaxel 49Magnetic Resonance Spectroscopy 49Aminolevulinic Acid 49binimetinib 48Carboplatin 48Specimen Handling 47Blood Specimen Collection 47cemiplimab 46Cisplatin 453-ingenyl angelate 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Melatonin × Dermatologic × Clear all
NCT05502900 2025-05-15

AMUM

St. Erik Eye Hospital

Phase 3 Recruiting
100 enrolled
Dermatologic

Uveal Melanoma

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown
48 enrolled
Dermatologic

Keratosis, Actinic

NCT02190838 2019-11-25

Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Terminated
57 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡